ClinicalTrials.Veeva

Menu

Cannabidiol Into Breastmilk (CBD-ALLT)

C

Centre Hospitalier Régional d'Orléans

Status

Enrolling

Conditions

Breast Feeding

Treatments

Biological: Assessing maternal and lactational plasma CBD uptake at different stages of breastfeeding

Study type

Interventional

Funder types

Other

Identifiers

NCT06589258
CHUO-2024-02

Details and patient eligibility

About

Really few data published to date on the passage of CBD into breast milk. The investigators known that 17.5 percent of the French human being between 18 and 34 years old consume CBD and among this, nearly half are women. None official French data to say how many French breastfeeding mothers consume CBD. CBD is a legal, psychoactive but not psychoaddictive substance. CBD's pharmacokinetic and pharmacodynamics make us fear that CBD could easily go through mother's milk. No published data available on possible effect in breast-fed child, not even on possible biological passage in breast-fed child. The aim of his study is to evaluate the passage of CBD in blood and milk at different moments of the breastfeeding (mothers) and its possible found in the infants'urine.

Enrollment

60 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women over 18
  • Breastfeeding CBD user
  • Having given written informed consent

Exclusion criteria

  • Women who do not understand French well
  • Women with a psychiatric or dual pathology that prevents proper participation in the study,
  • Women under protective supervision (guardianship/curatorship),
  • Women under court protection,
  • Women not affiliated to a social security scheme

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

60 participants in 1 patient group

breastfeeding mothers with CBD's consumption
Other group
Description:
Determination of delta 9-tetrahydrocannabinol (THC) and its metabolites , and of cannabidiol and its metabolites in blood and breast-milk by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Realization of THC/CBD ratio; qualitative research in mother's and breast-fed child's urine for the presence of cannabinoids (THC, CBD and its metabolites).
Treatment:
Biological: Assessing maternal and lactational plasma CBD uptake at different stages of breastfeeding

Trial contacts and locations

1

Loading...

Central trial contact

Elodie POUGOUE; Marie-Philippe LEBOUCHARD-MAAKAROUN, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems